Sustained efficacy and safety of infliximab in psoriasis: a retrospective study of 73 patients.

Journal of drugs in dermatology : JDD

Volumn 5, Issue 3, 2006, Pages 251-254

  Krathen, Richard A ^a   Berthelot, Cindy N ^a   Hsu, Sylvia ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONGITUDINAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; PATHOLOGY; PSORIASIS; RETROSPECTIVE STUDY; TREATMENT FAILURE; TREATMENT REFUSAL; UNITED STATES;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LONGITUDINAL STUDIES; MALE; MEDICAL RECORDS; MIDDLE AGED; PSORIASIS; RETROSPECTIVE STUDIES; TEXAS; TREATMENT FAILURE; TREATMENT REFUSAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33744536021     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)